cdn mobile

Delos Santos attributes rise in measles cases to Dengvaxia scare

By: Delta Dyrecka Comendador Letigio February 08,2019 - 01:35 PM

Cebu City Councilor Mary Ann Delos Santos, deputy mayor on health, talks to reporters about the rise in measles cases in the country. CDN Digital photo | Delta Dyrecka Comendador Letigio

Cebu City, Philippines – Cebu City Councilor Mary Anne Delos Santos, deputy mayor on health, attributes the increase of measles cases to the scare of the dengvaxia vaccine.

Delos Santos said that the fear of vaccination became widespread after the dengvaxia controversy, which began in 2017 after reports came out of children dying from various complications allegedly due to the dengue vaccine.

This scare led to parents avoiding vaccination of their children at Health Centers.

“Nangahadlok ang mga tawo tungod atong dengvaxia. Di na nuon nila ipavaccinate ilang mga anak. Nagtuo sila nga masakit ila anak sa vaccine,” Delos Santos said.

She said that the measles vaccine are free in all health centers in Cebu City but remained unused because of the low number of people availing the service.

De Los Santos assured parents that the measles vaccine provided by the government is safe.

But she knows it may take time before parents regain their trust in vaccines.

“It will take time to gain back the trust and confidence of the people,” said Delos Santos. /bmjo

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: cases, delos santos, Dengvaxia, measles, rise, scare, vaccine
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.